Photodynamic Therapy in Treating Patients With Lung Cancer
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of photodynamic therapy using
HPPH in treating patients with lung cancer. Photodynamic therapy uses a drug, such as HPPH,
that becomes active when it is exposed to a certain kind of light. When the drug is active,
cancer cells are killed.